134 related articles for article (PubMed ID: 22331745)
1. Metformin plus temozolomide-based chemotherapy as adjuvant treatment for WHO grade III and IV malignant gliomas.
Valle G; Carmignani M; Brunetti L; Volpe AR
J BUON; 2011; 16(4):787; author reply 787-8. PubMed ID: 22331745
[No Abstract] [Full Text] [Related]
2. Metformin plus temozolomide-based chemotherapy as adjuvant treatment for WHO grade III and IV malignant gliomas.
Soritau O; Tomuleasa C; Aldea M; Petrushev B; Susman S; Gheban D; Ioani H; Cosis A; Brie I; Irimie A; Kacso G; Florian IS
J BUON; 2011; 16(2):282-9. PubMed ID: 21766499
[TBL] [Abstract][Full Text] [Related]
3. Therapy for recurrent high-grade gliomas: does continuous dose-intense temozolomide have a role?
Wen PY
J Clin Oncol; 2010 Apr; 28(12):1977-9. PubMed ID: 20308652
[No Abstract] [Full Text] [Related]
4. Treating anaplastic oligodendrogliomas and WHO grade 2 gliomas: PCV or temozolomide? The case for PCV.
Levin VA
Oncology (Williston Park); 2015 Apr; 29(4):264, 266-8. PubMed ID: 25952490
[No Abstract] [Full Text] [Related]
5. Prolonged administration of temozolomide in adult patients with anaplastic glioma.
Freyschlag CF; Smolczyk DR; Janzen E; Schmieder K; Thomé C; Lohr F; Wenz F; Weiss C; Tuettenberg J; Seiz M
Anticancer Res; 2011 Nov; 31(11):3873-7. PubMed ID: 22110212
[TBL] [Abstract][Full Text] [Related]
6. High-grade gliomas: results in patients treated with adjuvant radiotherapy alone and with adjuvant radio-chemotherapy.
Valeriani M; Ferretti A; Franzese P; Tombolini V
Anticancer Res; 2006; 26(3B):2429-35. PubMed ID: 16821628
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant chemotherapy in the treatment of high grade gliomas.
Lonardi S; Tosoni A; Brandes AA
Cancer Treat Rev; 2005 Apr; 31(2):79-89. PubMed ID: 15847978
[TBL] [Abstract][Full Text] [Related]
8. Effects of palliative treatment with temozolomide in patients with high-grade gliomas.
Ziobro M; Rolski J; Grela-Wojewoda A; Zygulska A; Niemiec M
Neurol Neurochir Pol; 2008; 42(3):210-5. PubMed ID: 18651326
[TBL] [Abstract][Full Text] [Related]
9. Multicentre CRC phase II trial of temozolomide in recurrent or progressive high-grade glioma.
Bower M; Newlands ES; Bleehen NM; Brada M; Begent RJ; Calvert H; Colquhoun I; Lewis P; Brampton MH
Cancer Chemother Pharmacol; 1997; 40(6):484-8. PubMed ID: 9332462
[TBL] [Abstract][Full Text] [Related]
10. Temozolomide and radiation in low-grade and anaplastic gliomas: temoradiation.
Schiff D
Cancer Invest; 2007 Dec; 25(8):776-84. PubMed ID: 17952745
[TBL] [Abstract][Full Text] [Related]
11. Radiation combined with temozolomide contraindicated for young adults diagnosed with anaplastic glioma.
Yang P; Zhang C; Cai J; You G; Wang Y; Qiu X; Li S; Wu C; Yao K; Li W; Peng X; Zhang W; Jiang T
Oncotarget; 2016 Nov; 7(48):80091-80100. PubMed ID: 27590514
[TBL] [Abstract][Full Text] [Related]
12. Phase I trial of temozolomide using an extended continuous oral schedule.
Brock CS; Newlands ES; Wedge SR; Bower M; Evans H; Colquhoun I; Roddie M; Glaser M; Brampton MH; Rustin GJ
Cancer Res; 1998 Oct; 58(19):4363-7. PubMed ID: 9766665
[TBL] [Abstract][Full Text] [Related]
13. Prospective evaluation of radiotherapy with concurrent and adjuvant temozolomide in children with newly diagnosed diffuse intrinsic pontine glioma.
Jalali R; Raut N; Arora B; Gupta T; Dutta D; Munshi A; Sarin R; Kurkure P
Int J Radiat Oncol Biol Phys; 2010 May; 77(1):113-8. PubMed ID: 19647954
[TBL] [Abstract][Full Text] [Related]
14. A mathematical model of low grade gliomas treated with temozolomide and its therapeutical implications.
Bogdańska MU; Bodnar M; Belmonte-Beitia J; Murek M; Schucht P; Beck J; Pérez-García VM
Math Biosci; 2017 Jun; 288():1-13. PubMed ID: 28214527
[TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance imaging determination of tumor grade and early response to temozolomide in a genetically engineered mouse model of glioma.
McConville P; Hambardzumyan D; Moody JB; Leopold WR; Kreger AR; Woolliscroft MJ; Rehemtulla A; Ross BD; Holland EC
Clin Cancer Res; 2007 May; 13(10):2897-904. PubMed ID: 17504989
[TBL] [Abstract][Full Text] [Related]
16. Temozolomide in the treatment of recurrent malignant glioma.
Chang SM; Theodosopoulos P; Lamborn K; Malec M; Rabbitt J; Page M; Prados MD
Cancer; 2004 Feb; 100(3):605-11. PubMed ID: 14745879
[TBL] [Abstract][Full Text] [Related]
17. Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas.
Brandsma D; Stalpers L; Taal W; Sminia P; van den Bent MJ
Lancet Oncol; 2008 May; 9(5):453-61. PubMed ID: 18452856
[TBL] [Abstract][Full Text] [Related]
18. Dynamic history of low-grade gliomas before and after temozolomide treatment.
Ricard D; Kaloshi G; Amiel-Benouaich A; Lejeune J; Marie Y; Mandonnet E; Kujas M; Mokhtari K; Taillibert S; Laigle-Donadey F; Carpentier AF; Omuro A; Capelle L; Duffau H; Cornu P; Guillevin R; Sanson M; Hoang-Xuan K; Delattre JY
Ann Neurol; 2007 May; 61(5):484-90. PubMed ID: 17469128
[TBL] [Abstract][Full Text] [Related]
19. NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide.
Wick W; Hartmann C; Engel C; Stoffels M; Felsberg J; Stockhammer F; Sabel MC; Koeppen S; Ketter R; Meyermann R; Rapp M; Meisner C; Kortmann RD; Pietsch T; Wiestler OD; Ernemann U; Bamberg M; Reifenberger G; von Deimling A; Weller M
J Clin Oncol; 2009 Dec; 27(35):5874-80. PubMed ID: 19901110
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy of Diffuse Astrocytoma (WHO grade II) in Adults.
Narita Y
Prog Neurol Surg; 2018; 31():145-151. PubMed ID: 29393182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
